HOLX Hologic Inc

Price (delayed)

$78.63

Market cap

$18.35B

P/E Ratio

40.12

Dividend/share

N/A

EPS

$1.96

Enterprise value

$18.74B

Hologic, Inc. is a medical technology company primarily focused on women’s health; it sells medical devices for diagnostics, surgery, and medical imaging. In late November 2013, activist investor Carl Icahn ...

Highlights
The company's debt fell by 10% YoY
Hologic's quick ratio has decreased by 14% YoY but it has increased by 2.1% QoQ
HOLX's equity is down by 9% year-on-year but it is up by 4.1% since the previous quarter
The stock's price to earnings (P/E) is 39% more than its 5-year quarterly average of 28.6 and 4.3% more than its last 4 quarters average of 38.1
Hologic's net income has decreased by 38% YoY and by 9% QoQ

Key stats

What are the main financial stats of HOLX
Market
Shares outstanding
233.38M
Market cap
$18.35B
Enterprise value
$18.74B
Valuations
Price to book (P/B)
3.81
Price to sales (P/S)
4.68
EV/EBIT
27.78
EV/EBITDA
18.86
EV/Sales
4.73
Earnings
Revenue
$3.96B
EBIT
$674.6M
EBITDA
$993.4M
Free cash flow
$948.9M
Per share
EPS
$1.96
Free cash flow per share
$4.02
Book value per share
$20.64
Revenue per share
$16.79
TBVPS
$19.8
Balance sheet
Total assets
$8.71B
Total liabilities
$3.87B
Debt
$2.57B
Equity
$4.84B
Working capital
$2.83B
Liquidity
Debt to equity
0.53
Current ratio
3.97
Quick ratio
2.96
Net debt/EBITDA
0.39
Margins
EBITDA margin
25.1%
Gross margin
49.9%
Net margin
11.8%
Operating margin
13.7%
Efficiency
Return on assets
5.2%
Return on equity
9.5%
Return on invested capital
16.6%
Return on capital employed
8.7%
Return on sales
17%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

HOLX stock price

How has the Hologic stock price performed over time
Intraday
0.96%
1 week
0.67%
1 month
8.8%
1 year
-3.99%
YTD
10.05%
QTD
5.9%

Financial performance

How have Hologic's revenue and profit performed over time
Revenue
$3.96B
Gross profit
$1.98B
Operating income
$541.7M
Net income
$466.5M
Gross margin
49.9%
Net margin
11.8%
Hologic's operating income has decreased by 39% YoY and by 8% QoQ
The operating margin has contracted by 38% YoY and by 8% from the previous quarter
Hologic's net income has decreased by 38% YoY and by 9% QoQ
The company's net margin fell by 37% YoY and by 9% QoQ

Growth

What is Hologic's growth rate over time

Valuation

What is Hologic stock price valuation
P/E
40.12
P/B
3.81
P/S
4.68
EV/EBIT
27.78
EV/EBITDA
18.86
EV/Sales
4.73
The stock's price to earnings (P/E) is 39% more than its 5-year quarterly average of 28.6 and 4.3% more than its last 4 quarters average of 38.1
The EPS has declined by 35% year-on-year and by 8% since the previous quarter
HOLX's price to book (P/B) is 16% lower than its 5-year quarterly average of 4.5
HOLX's equity is down by 9% year-on-year but it is up by 4.1% since the previous quarter
HOLX's price to sales (P/S) is 19% higher than its 5-year quarterly average of 3.9 and 3.1% higher than its last 4 quarters average of 4.5
The revenue has contracted by 2.4% YoY

Efficiency

How efficient is Hologic business performance
The ROE has contracted by 36% YoY and by 7% from the previous quarter
Hologic's return on assets has decreased by 36% YoY and by 9% QoQ
HOLX's return on invested capital is down by 32% year-on-year and by 8% since the previous quarter
The return on sales has declined by 32% year-on-year and by 9% since the previous quarter

Dividends

What is HOLX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for HOLX.

Financial health

How did Hologic financials performed over time
The total assets is 125% higher than the total liabilities
Hologic's quick ratio has decreased by 14% YoY but it has increased by 2.1% QoQ
Hologic's current ratio has decreased by 10% YoY but it has increased by 2.1% from the previous quarter
The company's debt is 47% lower than its equity
The company's debt fell by 10% YoY
HOLX's equity is down by 9% year-on-year but it is up by 4.1% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.